Trial Profile
Effects of therapeutic and supratherapeutic doses of linagliptin on QT intervals in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Aug 2014
Price :
$35
*
At a glance
- Drugs Linagliptin (Primary) ; Moxifloxacin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Boehringer Ingelheim
- 04 Apr 2011 New trial record